ImmunityBio, Inc. (IBRX)
7.78
-0.22
(-2.75%)
USD |
NASDAQ |
May 19, 16:00
7.78
0.00 (0.00%)
After-Hours: 17:32
ImmunityBio EPS Diluted (Quarterly) : -0.6162 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Atara Biotherapeutics, Inc. | -0.2944 |
| Gilead Sciences, Inc. | 1.612 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Neurocrine Biosciences, Inc. | 1.914 |
| Iovance Biotherapeutics, Inc. | -0.1889 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -632.80M |
| Revenue (Quarterly) | 44.21M |
| Total Expenses (Quarterly) | 676.99M |
| Enterprise Value | 9.123B |
| Gross Profit Margin (Quarterly) | 89.55% |
| Profit Margin (Quarterly) | -1.43K% |
| Earnings Yield | -10.98% |
| Normalized Earnings Yield | -6.794 |